Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FZX18
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,488
Award facts
- Contract value 100% obligated
- $18,488.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this delivery order from its Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. As a significant supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured contracts to deliver branded and generic prescription medications, biologics, and medical consumables to military health facilities. Trikafta, a cystic fibrosis treatment medication, represents one of the specialized pharmaceutical products within the contractor's extensive portfolio of federal healthcare deliveries.
Quick answers
Who was awarded contract SPE2DB25FZX18?
SPE2DB25FZX18 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 6, 2025.
How much is contract SPE2DB25FZX18 worth?
The government has obligated $18,488 on SPE2DB25FZX18.
Is contract SPE2DB25FZX18 an order under another contract?
Yes. SPE2DB25FZX18 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX18 competed?
The extent of competition for SPE2DB25FZX18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award